Outpatient Management of Community-associated Methicillin-resistant Staphylococcus aureus Skin and Soft Tissue Infection

References 

1. Abrams, T., Bancroft, E., Apgar, F., Belmusto, V. E., Blake, R., Blumberg, D., … Blumber, D. (2008). CA-MRSA: California's call to action. Retrieved from www.aware.md/HealthcareProfessional/CAMRSA
2. Association for Professionals in Infection and Epidemiology. (2007). National prevalence study of methicillin-resistant Staphylococcus aureus (MRSA) in U.S. healthcare facilities. Retrieved from www.APIC.org
3. Brandon, C., Cecil, B., Weaver, C., Heaton, L., Todd, N., & Simmons, B. (2008). Methicillin-resistant Staphylococcus aureus infection: Program report and recommendations of the Tennessee Department of Health and the Infectious Task Force. Retrieved from http://www.health.state.tn.us.com
4. Bradley JS, Nelson JD. 2008-2009 Nelson's pocket book of pediatric antimicrobial therapy. 17 ed.. Buenos Aires, Argentina: Alliance for World Wide Editing; 2008;
5. Centers for Disease Control and Prevention. (2007). Outpatient management of skin and soft tissue infections in the era of community-associated MRSA. Retrieved from www.cdc.gov/MRSA
6. D'Agata EM, Webb GF, Horn MA, Mollering RC, Ruan S. Modeling the invasion of community-acquired methicillin-resistant Staphylococcus aureus into hospitals. Clinical Infection Diseases. 2009;48:274–284
7. Dellit, T.H., & Duchin, J. (2007). Guidelines forevaluation and management of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections in outpatient settings. Retrieved from http://www.doh.wa.gov/Topics/Antibiotics/providers.htm
8. Deuremberg RH, Vink C, Kalenic S, Friedrich AW, Bruggerman CA, Stobberingh EE. The molecular evolution of methicillin-resistant Staphylococcus aureus. Clinical Microbiology. 2006;13:222–235
9. Drews TD, Temte JL, Fox BC. Community-associated methicillin-resistant Staphylococcus aureus: Review of an emerging health concern. Wisconsin Medical Journal. 2006;105:52–57
10. Elliott DJ, Zaoutis TE, Troxel AB, Loh A, Keren R. Empiric antimicrobial therapy for pediatric skin and soft-tissue infections in the era of methicillin-resistant Staphylococcus aureus. Pediatrics. 2009;123(6):E959–E966
    • CrossRef
11. Farley JE. Epidemiology, clinical manifestations, and treatment options for skin and soft tissue infection caused by community-acquired methicillin-resistant Staphylococcus aureus. American Academy of Nurse Practitioners. 2008;20:85–92
12. Fey PD, Said-Salim B, Rupp ME, Hinrichs SH, Boxrud DJ, et al., Schlievert PM Comparative molecular analysis of community or hospital acquired methicillin-resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 2003;47:196–203
    • MEDLINE
    • CrossRef
13. File TM. Impact of community-acquired methicillin-resistant Staphylococcus aureus in the hospital setting. Cleveland Clinic Journal of Medicine. 2007;74:S6–S10
    • CrossRef
14. Fisher RG, Chain RL, Hair PS. Hypochlorite killing of community-acquired methicillin-resistant Staphylococcus aureus. Journal of Pediatric Infectious Disease. 2008;27:934–935
15. Gorwitz RJ. A review of community-associated methicillin-resistant Staphylococcus aureus and soft tissue infections. Pediatric Infectious Disease Journal. 2008;27:1–5
16. Gorwitz, R.J., Jernigan, D.B., Powers, J.H., Jernigan, J.A., and Participants in the Centers for Disease Control and Prevention-Convened Experts' Meeting on Management of MRSA in the Community. (2006). Strategies for clinical management of MRSA in the community. Retrieved from http://www.cdc.gov
17. Hersch AL, Henry F, Chambers MD, Maselli JH, Gonzales R. National trends in ambulatory visits and antibiotic prescribing for skin and soft tissue infections. Archives of Internal Medicine. 2008;168:1585–1591
    • CrossRef
18. Huang H, Flynn NM, King JH, Monchaud C, Morita M, Cohen SH. Comparisons of community-associated methicillin-resistant Staphylococcus aureus (MRSA) and hospital-associated MRSA infections in Sacramento, California. Journal of Clinical Microbiology. 2006;44:2423–2427
    • MEDLINE
    • CrossRef
19. Le J, Lieberman JM. Management of community-associated methicillin-resistant Staphylococcus aureus infections in children. Journal of Pharmacotherapy. 2006;26:1758–1770
20. Olesevich M, Kennedy A. Emergence of community-acquired methicillin-resistant Staphylococcus aureus soft tissue infection. Journal of Pediatric Surgery. 2006;42:765–768
    • Abstract
    • Full Text
    • Full-Text PDF (86 KB)
    • CrossRef
21. Pope ND. Methicillin-resistant Staphylococcus aureus skin and soft tissue infections. US Pharmacology. 2009;34:HS8–HS15
22. Popovich KJ, Hota B. Treatment and prevention of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections. Dermatologic Therapy. 2008;21:167–169
    • CrossRef
23. Raygada JL, Levine DP. Managing CA-MRSA infections: Current and emerging options. Infections in Medicine. 2009;26:49–58
24. Sanchez PJ. CA-MRSA: Preventing, managing leading culprit in skin, soft tissue infections. Infectious Disease News. 2009, March;Retrieved from http://infectiousdiseasenews.com/article.aspx?id=37804
25. Siberry GK. The Harriet Lane Handbook. 15th ed.. St. Louis, MO: Mosby; 2000;
26. Stroube R. CA-MRSA: How should we respond to outbreaks. Medscape. 2008;Retrieved from www.medscape.com.wa
27. Stevens DL, Bisno AL, Chambers HF, Everett ED, Dellinger P, et al., Wade JC Practice guidelines for the diagnosis and management of skin and soft tissue infections. Clinical Infectious Diseases. 2005;41:1373–1380
28. Taketomo CK, Hodding JH, Kraus DM. Pediatric dosage handbook. 6th ed.. Hudson, Ohio: Lexi-Comp; 2009;
29. Wilson BA, Shannon MT, Shields KM. Pearson Nurses Drug Guide. New York: Pearson; 2011;